NDC 72934-1128

IMIQUIMOD 5% / SALICYLIC ACID 30% / TRETINOIN 0.1%

Imiquimod 5% / Salicylic Acid 30% / Tretinoin 0.1%

IMIQUIMOD 5% / SALICYLIC ACID 30% / TRETINOIN 0.1% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Salicylic Acid; Tretinoin; Imiquimod.

Product ID72934-1128_883a24d3-e5fe-4329-e053-2995a90a9758
NDC72934-1128
Product TypeHuman Prescription Drug
Proprietary NameIMIQUIMOD 5% / SALICYLIC ACID 30% / TRETINOIN 0.1%
Generic NameImiquimod 5% / Salicylic Acid 30% / Tretinoin 0.1%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-07
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameSALICYLIC ACID; TRETINOIN; IMIQUIMOD
Active Ingredient Strength30 g/100g; g/100g; g/100g
Pharm ClassesRetinoid [EPC],Retinoids [CS],Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1128-2

30 g in 1 BOTTLE, PUMP (72934-1128-2)
Marketing Start Date2019-05-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1128-2 [72934112802]

IMIQUIMOD 5% / SALICYLIC ACID 30% / TRETINOIN 0.1% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-07

Drug Details

Active Ingredients

IngredientStrength
SALICYLIC ACID30 g/100g

Pharmacological Class

  • Retinoid [EPC]
  • Retinoids [CS]
  • Increased Cytokine Activity [PE]
  • Increased Cytokine Production [PE]
  • Interferon Inducers [MoA]
  • Retinoid [EPC]
  • Retinoids [CS]
  • Increased Cytokine Activity [PE]
  • Increased Cytokine Production [PE]
  • Interferon Inducers [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.